{"schema_version":"secwatch.filing_event.v1","accession":"0001699350-26-000050","form_type":"8-K","ticker":"SI","cik":"0001699350","company_name":"SHOULDER INNOVATIONS, INC.","filed_at":"2026-08-06T20:12:48+00:00","discovered_at":"2026-08-06T20:14:01.265716+00:00","generated_at":"2026-08-06T20:17:38.965382+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Shoulder Innovations Q2 revenue $17.2M (+56% YoY); raises FY2026 guidance to $67-69M","bullets":["Net revenue $17.2M, up 56% YoY; gross margin 78.3% vs 76.2% a year ago.","Implant systems sold 2,238 (+50% YoY); average selling price $7,674 (+5%).","Full year 2026 revenue guidance raised to $67-69M (prior $65-68M), ~42-46% growth.","Net loss $10.2M vs $19.2M in Q2 2025; adjusted EBITDA loss $8.0M vs $18.1M.","Closed two credit facilities totaling up to $50M with Stifel Venture Banking; cash $99M."],"urls":{"canonical":"https://secwatch.observer/filing/0001699350-26-000050","json":"https://secwatch.observer/filing/0001699350-26-000050.json","markdown":"https://secwatch.observer/filing/0001699350-26-000050.md","text":"https://secwatch.observer/filing/0001699350-26-000050.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1699350/000169935026000050/0001699350-26-000050-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1699350/000169935026000050/si-20260806.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-06T20:17:38.965382+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}